Evidence map›Paper›PMID 26218804›Full record

ArticleFoodborne pathogens and disease2015

Reduction of Salmonella Enteritidis in the spleens of hens by bacterins that vary in fimbrial protein SefD.

Roxana Sanchez-Ingunza, Jean Guard, Cesar A Morales, Alan H Icard

Open access · bronzeAbstract read
In one paragraph

Article in Foodborne pathogens and disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. AT Homopolymer Strings inMicroorganisms · 2021
    Article
  2. Serotyping ofFood safety (Tokyo, Japan) · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Roxana Sanchez-Ingunza1 CEVA Biomune , Lenexa, Kansas.
Jean Guard2 U.S. Department of Agriculture, Agricultural Research Service, Athens, Georgia .
Cesar A Morales2 U.S. Department of Agriculture, Agricultural Research Service, Athens, Georgia .
Alan H Icard3 Grafton Scientific Staffing Companies , Leawood, Kansas.
United States Department of Agriculture · USAmerican College of Clinical Pharmacy · USNew England Disabled Sports · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this research was to determine whether variation in the presence of fimbrial protein SefD would impact efficacy of bacterins as measured by recovery of Salmonella enterica serovar Enteritidis (Salmonella Enteritidis) from the spleens of hens. Two bacterins were prepared that varied in SefD content. Also, two adjuvants were tested, namely, water-in-oil and aluminum hydroxide gel (alum). Control groups for both adjuvant preparations included infected nonvaccinated hens and uninfected nonvaccinated hens. At 21 days postinfection, Salmonella Enteritidis was recovered from 69.7%, 53.1%, and 86.0% from the spleens of all hens vaccinated with bacterins lacking SefD, bacterins that included SefD, and infected nonvaccinated control hens, respectively. No Salmonella was recovered from uninfected nonvaccinates. Results from individual trials showed that both bacterins reduced positive spleens, but that the one with SefD was more efficacious. Alum adjuvant had fewer side effects on hens and egg production as compared to water-in-oil. However, adjuvant did not change the relative recovery of Salmonella Enteritidis from spleens. These results suggest that SefD is a promising target antigen for improving the efficacy of immunotherapy in hens, and is intended to reduce Salmonella Enteritidis in the food supply.

Indexed as

ChickensAnimalsBacterial VaccinesCell Adhesion MoleculesFemaleFimbriae ProteinsPoultry DiseasesSalmonella enteritidisSalmonella Infections, AnimalSpleenBacterial VaccinesCell Adhesion MoleculesFimbriae ProteinsSefD protein, Salmonella

Identifiers

PMID26218804
PMCPMC4601671
OpenAlexW1816992121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.